Transaction · 0001193125-26-361489

Chi Jeffrey

Chi Jeffrey, DIR, reported a transaction classified as grant at Aardvark Therapeutics, Inc. involving 44964.000000 shares for an estimated $0.00. Reported holdings after the transaction were 44964.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
AARDAardvark Therapeutics, Inc.
Trade date
Aug 14, 2026
Filing date
Aug 21, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded44.9k$0.00 per share
Holdings after44.9kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 7 calendar days after the transaction date.

AARD price since this filing

Daily closing prices, with the filing date and available return windows
AARD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.2%1w ago +15.8%1d ago -6.0%
Returns since7d +0.9%30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-361489
Stock Option (right to buy)
Transaction date
Aug 14, 2026
Filed Aug 21, 2026, 11:48 PM · 7d delay
Shares
44,964 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
44,964 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • delayed_filing-6 points

    reporting_delay_days = 7

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The option shall vest in full on the earlier of (i) August 14, 2027, and (ii) immediately prior to the Registrant's next Annual Meeting of Stockholders following the date of grant, subject to the Repo…

Original filing · 0001193125-26-361489
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AARD